Soft-tissue  ||| S:0 E:12 ||| JJ
fillers  ||| S:12 E:20 ||| JJ
Injections  ||| S:20 E:31 ||| NNS
of  ||| S:31 E:34 ||| IN
soft-tissue  ||| S:34 E:46 ||| JJ
fillers  ||| S:46 E:54 ||| NNS
have  ||| S:54 E:59 ||| VBP
rapidly  ||| S:59 E:67 ||| RB
become  ||| S:67 E:74 ||| VB
accessible  ||| S:74 E:85 ||| JJ
and  ||| S:85 E:89 ||| CC
essential ||| S:89 E:98 ||| JJ
.  ||| S:98 E:100 ||| .
When  ||| S:100 E:105 ||| WRB
dealing  ||| S:105 E:113 ||| VBG
with  ||| S:113 E:118 ||| IN
facial  ||| S:118 E:125 ||| JJ
aging ||| S:125 E:130 ||| NN
,  ||| S:130 E:132 ||| ,
it  ||| S:132 E:135 ||| PRP
is  ||| S:135 E:138 ||| VBZ
logical  ||| S:138 E:146 ||| JJ
to  ||| S:146 E:149 ||| TO
compensate  ||| S:149 E:160 ||| VB
for  ||| S:160 E:164 ||| IN
the  ||| S:164 E:168 ||| DT
loss  ||| S:168 E:173 ||| NN
of  ||| S:173 E:176 ||| IN
volume ||| S:176 E:182 ||| NN
,  ||| S:182 E:184 ||| ,
but  ||| S:184 E:188 ||| CC
the  ||| S:188 E:192 ||| DT
optimisation  ||| S:192 E:205 ||| NN
of  ||| S:205 E:208 ||| IN
a  ||| S:208 E:210 ||| DT
younger  ||| S:210 E:218 ||| JJR
face  ||| S:218 E:223 ||| NN
involves  ||| S:223 E:232 ||| VBZ
a  ||| S:232 E:234 ||| DT
3D  ||| S:234 E:237 ||| JJ
strategy  ||| S:237 E:246 ||| NN
as  ||| S:246 E:249 ||| IN
well ||| S:249 E:253 ||| RB
.  ||| S:253 E:255 ||| .
